Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Železná B[au]:

The effects of liraglutide in mice with diet-induced obesity studied by metabolomics. Bugáňová M et al. J Endocrinol. (2017)

The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology. Maletínská L et al. J Endocrinol. (2019)

Prolactin-releasing peptide improved leptin hypothalamic signaling in obese mice. Holubová M et al. J Mol Endocrinol. (2018)

Search results

Items: 1 to 50 of 86

1.

Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology?

Kacířová M, Zmeškalová A, Kořínková L, Železná B, Kuneš J, Maletínská L.

Clin Sci (Lond). 2020 Mar 13;134(5):547-570. doi: 10.1042/CS20191313.

PMID:
32167154
2.

Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice.

Kořínková L, Holubová M, Neprašová B, Hrubá L, Pražienková V, Bencze M, Haluzík M, Kuneš J, Maletínská L, Železná B.

J Mol Endocrinol. 2020 Feb;64(2):77-90. doi: 10.1530/JME-19-0188.

PMID:
31855558
3.

Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats.

Čermáková M, Pelantová H, Neprašová B, Šedivá B, Maletínská L, Kuneš J, Tomášová P, Železná B, Kuzma M.

J Proteome Res. 2019 Apr 5;18(4):1735-1750. doi: 10.1021/acs.jproteome.8b00964. Epub 2019 Mar 11.

PMID:
30810318
4.

Lipidized Prolactin-Releasing Peptide Agonist Attenuates Hypothermia-Induced Tau Hyperphosphorylation in Neurons.

Pražienková V, Schirmer C, Holubová M, Železná B, Kuneš J, Galas MC, Maletínská L.

J Alzheimers Dis. 2019;67(4):1187-1200. doi: 10.3233/JAD-180837.

PMID:
30689580
5.

The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.

Maletínská L, Popelová A, Železná B, Bencze M, Kuneš J.

J Endocrinol. 2019 Feb 1;240(2):R47-R72. doi: 10.1530/JOE-18-0532. Review.

PMID:
30475219
6.

Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.

Holubová M, Hrubá L, Popelová A, Bencze M, Pražienková V, Gengler S, Kratochvílová H, Haluzík M, Železná B, Kuneš J, Hölscher C, Maletínská L.

Neuropharmacology. 2019 Jan;144:377-387. doi: 10.1016/j.neuropharm.2018.11.002. Epub 2018 Nov 11.

PMID:
30428311
7.

Metabolomics Based on MS in Mice with Diet-Induced Obesity and Type 2 Diabetes Mellitus: the Effect of Vildagliptin, Metformin, and Their Combination.

Tomášová P, Bugáňová M, Pelantová H, Holubová M, Šedivá B, Železná B, Haluzík M, Maletínská L, Kuneš J, Kuzma M.

Appl Biochem Biotechnol. 2019 May;188(1):165-184. doi: 10.1007/s12010-018-2899-8. Epub 2018 Nov 5.

PMID:
30393821
8.

In Vitro and In Vivo Characterization of Novel Stable Peptidic Ghrelin Analogs: Beneficial Effects in the Settings of Lipopolysaccharide-Induced Anorexia in Mice.

Holubová M, Blechová M, Kákonová A, Kuneš J, Železná B, Maletínská L.

J Pharmacol Exp Ther. 2018 Sep;366(3):422-432. doi: 10.1124/jpet.118.249086. Epub 2018 Jun 18.

PMID:
29914876
9.

Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.

Popelová A, Pražienková V, Neprašová B, Kasperová BJ, Hrubá L, Holubová M, Zemenová J, Blum D, Železná B, Galas MC, Kuneš J, Maletínská L.

J Alzheimers Dis. 2018;62(4):1725-1736. doi: 10.3233/JAD-171041.

PMID:
29614684
10.

Repeated peripheral administration of lipidized prolactin-releasing peptide analog induces c-fos and FosB expression in neurons of dorsomedial hypothalamic nucleus in male C57 mice.

Pirník Z, Kolesárová M, Železná B, Maletínská L.

Neurochem Int. 2018 Jun;116:77-84. doi: 10.1016/j.neuint.2018.03.013. Epub 2018 Mar 27.

PMID:
29601847
11.

Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.

Mikulášková B, Holubová M, Pražienková V, Zemenová J, Hrubá L, Haluzík M, Železná B, Kuneš J, Maletínská L.

Nutr Diabetes. 2018 Jan 16;8(1):5. doi: 10.1038/s41387-017-0015-8.

12.

Potential neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: an in vitro study using SH-SY5Y cells.

Popelová A, Kákonová A, Hrubá L, Kuneš J, Maletínská L, Železná B.

Physiol Res. 2018 May 4;67(2):339-346. Epub 2018 Jan 5.

13.

Prolactin-releasing peptide improved leptin hypothalamic signaling in obese mice.

Holubová M, Hrubá L, Neprašová B, Majerčíková Z, Lacinová Z, Kuneš J, Maletínská L, Železná B.

J Mol Endocrinol. 2018 Feb;60(2):85-94. doi: 10.1530/JME-17-0171. Epub 2017 Dec 12.

PMID:
29233862
14.

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity.

Pražienková V, Holubová M, Pelantová H, Bugáňová M, Pirník Z, Mikulášková B, Popelová A, Blechová M, Haluzík M, Železná B, Kuzma M, Kuneš J, Maletínská L.

PLoS One. 2017 Aug 18;12(8):e0183449. doi: 10.1371/journal.pone.0183449. eCollection 2017.

15.

The effects of liraglutide in mice with diet-induced obesity studied by metabolomics.

Bugáňová M, Pelantová H, Holubová M, Šedivá B, Maletínská L, Železná B, Kuneš J, Kačer P, Kuzma M, Haluzík M.

J Endocrinol. 2017 Apr;233(1):93-104. doi: 10.1530/JOE-16-0478. Epub 2017 Jan 30.

PMID:
28138003
16.

Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination.

Pelantová H, Bugáňová M, Holubová M, Šedivá B, Zemenová J, Sýkora D, Kaválková P, Haluzík M, Železná B, Maletínská L, Kuneš J, Kuzma M.

Mol Cell Endocrinol. 2016 Aug 15;431:88-100. doi: 10.1016/j.mce.2016.05.003. Epub 2016 May 7.

PMID:
27164444
17.

Pharmacological characterization of lipidized analogs of prolactin-releasing peptide with a modified C- terminal aromatic ring.

Prazienkova V, Ticha A, Blechova M, Spolcova A, Zelezna B, Maletinska L.

J Physiol Pharmacol. 2016 Feb;67(1):121-8.

18.

Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats.

Holubová M, Zemenová J, Mikulášková B, Panajotova V, Stöhr J, Haluzík M, Kuneš J, Železná B, Maletínská L.

J Endocrinol. 2016 May;229(2):85-96. doi: 10.1530/JOE-15-0519. Epub 2016 Feb 23.

PMID:
26906745
19.

Effect of palmitoylated prolactin-releasing peptide on food intake and neural activation after different routes of peripheral administration in rats.

Mikulášková B, Zemenová J, Pirník Z, Pražienková V, Bednárová L, Železná B, Maletínská L, Kuneš J.

Peptides. 2016 Jan;75:109-17. doi: 10.1016/j.peptides.2015.11.005. Epub 2015 Nov 28.

PMID:
26643957
20.

Metabolomic profiling of urinary changes in mice with monosodium glutamate-induced obesity.

Pelantová H, Bártová S, Anýž J, Holubová M, Železná B, Maletínská L, Novák D, Lacinová Z, Šulc M, Haluzík M, Kuzma M.

Anal Bioanal Chem. 2016 Jan;408(2):567-78. doi: 10.1007/s00216-015-9133-0. Epub 2015 Nov 17.

PMID:
26577083
21.

Peripheral administration of palmitoylated prolactin-releasing peptide induces Fos expression in hypothalamic neurons involved in energy homeostasis in NMRI male mice.

Pirnik Z, Železná B, Kiss A, Maletínská L.

Brain Res. 2015 Nov 2;1625:151-8. doi: 10.1016/j.brainres.2015.08.042. Epub 2015 Sep 8.

PMID:
26362395
22.

Strategy for NMR metabolomic analysis of urine in mouse models of obesity--from sample collection to interpretation of acquired data.

Pelantová H, Bugáňová M, Anýž J, Železná B, Maletínská L, Novák D, Haluzík M, Kuzma M.

J Pharm Biomed Anal. 2015 Nov 10;115:225-35. doi: 10.1016/j.jpba.2015.06.036. Epub 2015 Jul 17.

PMID:
26263053
23.

Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.

Maletínská L, Nagelová V, Tichá A, Zemenová J, Pirník Z, Holubová M, Špolcová A, Mikulášková B, Blechová M, Sýkora D, Lacinová Z, Haluzík M, Železná B, Kuneš J.

Int J Obes (Lond). 2015 Jun;39(6):986-93. doi: 10.1038/ijo.2015.28. Epub 2015 Mar 16.

PMID:
25771926
24.

Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.

Špolcová A, Mikulášková B, Holubová M, Nagelová V, Pirnik Z, Zemenová J, Haluzík M, Železná B, Galas MC, Maletínská L.

J Alzheimers Dis. 2015;45(3):823-35. doi: 10.3233/JAD-143150.

PMID:
25624414
25.

Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats.

Špolcová A, Mikulášková B, Kršková K, Gajdošechová L, Zórad Š, Olszanecki R, Suski M, Bujak-Giżycka B, Železná B, Maletínská L.

BMC Neurosci. 2014 Sep 25;15:111. doi: 10.1186/1471-2202-15-111.

26.
27.

Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice.

Holubová M, Nagelová V, Lacinová Z, Haluzík M, Sýkora D, Moulin A, Blayo AL, Fehrentz JA, Martinez J, Stofkova A, Jurčovičová J, Zelezná B, Maletínská L.

Mol Cell Endocrinol. 2014 Aug 5;393(1-2):120-8. doi: 10.1016/j.mce.2014.06.003. Epub 2014 Jun 20.

PMID:
24953973
28.

Changes in FGF21 serum concentrations and liver mRNA expression in an experimental model of complete lipodystrophy and insulin-resistant diabetes.

Spolcová A, Holubová M, Mikulášková B, Nagelová V, Stofková A, Lacinová Z, Jurčovičová J, Haluzík M, Maletínská L, Zelezná B.

Physiol Res. 2014;63(4):483-90. Epub 2014 Jun 5.

29.

CART (cocaine- and amphetamine-regulated transcript) peptide specific binding sites in PC12 cells have characteristics of CART peptide receptors.

Nagelová V, Pirník Z, Železná B, Maletínská L.

Brain Res. 2014 Feb 14;1547:16-24. doi: 10.1016/j.brainres.2013.12.024. Epub 2013 Dec 27.

PMID:
24378198
30.

Ghrelin agonist JMV 1843 increases food intake, body weight and expression of orexigenic neuropeptides in mice.

Holubová M, Spolcová A, Demianová Z, Sýkora D, Fehrentz JA, Martinez J, Stofková A, Jurčovičová J, Drápalová J, Lacinová Z, Haluzík M, Zelezná B, Maletínská L.

Physiol Res. 2013;62(4):435-44. Epub 2013 Apr 16.

31.

Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administration.

Maletínská L, Tichá A, Nagelová V, Spolcová A, Blechová M, Elbert T, Zelezná B.

Brain Res. 2013 Mar 1;1498:33-40. doi: 10.1016/j.brainres.2012.12.037. Epub 2013 Jan 3. Erratum in: Brain Res. 2013 Mar 29;1503:108.

PMID:
23291266
32.

New analogs of the CART peptide with anorexigenic potency: the importance of individual disulfide bridges.

Blechová M, Nagelová V, Záková L, Demianová Z, Zelezná B, Maletínská L.

Peptides. 2013 Jan;39:138-44. doi: 10.1016/j.peptides.2012.09.033. Epub 2012 Nov 19.

PMID:
23174349
33.

Characterization of new stable ghrelin analogs with prolonged orexigenic potency.

Maletínská L, Pýchová M, Holubová M, Blechová M, Demianová Z, Elbert T, Železná B.

J Pharmacol Exp Ther. 2012 Mar;340(3):781-6. doi: 10.1124/jpet.111.185371. Epub 2011 Dec 19.

PMID:
22182933
34.

Biological properties of prolactin-releasing peptide analogs with a modified aromatic ring of a C-terminal phenylalanine amide.

Maletínská L, Spolcová A, Maixnerová J, Blechová M, Zelezná B.

Peptides. 2011 Sep;32(9):1887-92. doi: 10.1016/j.peptides.2011.08.011. Epub 2011 Aug 19.

PMID:
21872625
35.

Ghrelin agonists impact on Fos protein expression in brain areas related to food intake regulation in male C57BL/6 mice.

Pirnik Z, Bundziková J, Holubová M, Pýchová M, Fehrentz JA, Martinez J, Zelezná B, Maletínská L, Kiss A.

Neurochem Int. 2011 Nov;59(6):889-95. doi: 10.1016/j.neuint.2011.08.001. Epub 2011 Aug 6.

PMID:
21843570
36.

The Peptidic GHS-R antagonist [D-Lys(3)]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity.

Maletínská L, Matyšková R, Maixnerová J, Sýkora D, Pýchová M, Spolcová A, Blechová M, Drápalová J, Lacinová Z, Haluzík M, Zelezná B.

Mol Cell Endocrinol. 2011 Aug 22;343(1-2):55-62. doi: 10.1016/j.mce.2011.06.006. Epub 2011 Jun 17. Erratum in: Mol Cell Endocrinol. 2012 Jan 2;348(1):344.

PMID:
21704671
37.

Characterization of prolactin-releasing peptide: binding, signaling and hormone secretion in rodent pituitary cell lines endogenously expressing its receptor.

Maixnerová J, Špolcová A, Pýchová M, Blechová M, Elbert T, Rezáčová M, Zelezná B, Maletínská L.

Peptides. 2011 Apr;32(4):811-7. doi: 10.1016/j.peptides.2010.12.011. Epub 2010 Dec 23.

PMID:
21185342
38.

Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats.

Stofkova A, Zelezna B, Romzova M, Ulicna O, Kiss A, Skurlova M, Jurcovicova J.

Mediators Inflamm. 2010;2010. pii: 398026. doi: 10.1155/2010/398026. Epub 2010 Sep 30.

39.

Estradiol supplementation helps overcome central leptin resistance of ovariectomized mice on a high fat diet.

Matysková R, Zelezná B, Maixnerová J, Koutová D, Haluzík M, Maletínská L.

Horm Metab Res. 2010 Mar;42(3):182-6. doi: 10.1055/s-0029-1243250. Epub 2010 Jan 4. Erratum in: Horm Metab Res. 2010 Mar;42(3). doi: 10.1055/s-0030-1247520.

PMID:
20049675
40.

Effect of anorexinergic peptides, cholecystokinin (CCK) and cocaine and amphetamine regulated transcript (CART) peptide, on the activity of neurons in hypothalamic structures of C57Bl/6 mice involved in the food intake regulation.

Pirnik Z, Maixnerová J, Matysková R, Koutová D, Zelezná B, Maletínská L, Kiss A.

Peptides. 2010 Jan;31(1):139-44. doi: 10.1016/j.peptides.2009.09.035. Epub 2009 Oct 8.

PMID:
19818819
41.

Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.

Stofkova A, Skurlova M, Kiss A, Zelezna B, Zorad S, Jurcovicova J.

Endocr Regul. 2009 Jul;43(3):99-106.

PMID:
19817504
42.

Enhanced expressions of mRNA for neuropeptide Y and interleukin 1 beta in hypothalamic arcuate nuclei during adjuvant arthritis-induced anorexia in Lewis rats.

Stofkova A, Haluzik M, Zelezna B, Kiss A, Skurlova M, Lacinova Z, Jurcovicova J.

Neuroimmunomodulation. 2009;16(6):377-84. doi: 10.1159/000228912. Epub 2009 Jul 17.

PMID:
19609086
43.

Anorexigenic effect of cholecystokinin is lost but that of CART (Cocaine and Amphetamine Regulated Transcript) peptide is preserved in monosodium glutamate obese mice.

Zelezná B, Maixnerová J, Matysková R, Haugvicová R, Blokesová D, Maletínská L.

Physiol Res. 2009;58(5):717-23. Epub 2008 Nov 4.

44.

Fos expression in hypocretinergic neurons in C57B1/6 male and female mice after long-term consumption of high fat diet.

Pirnik Z, Bundzikova J, Mikkelsen JD, Zelezna B, Maletinska L, Kiss A.

Endocr Regul. 2008 Sep;42(4):137-46.

PMID:
18999901
45.

Synergistic effect of CART (cocaine- and amphetamine-regulated transcript) peptide and cholecystokinin on food intake regulation in lean mice.

Maletínská L, Maixnerová J, Matysková R, Haugvicová R, Pirník Z, Kiss A, Zelezná B.

BMC Neurosci. 2008 Oct 21;9:101. doi: 10.1186/1471-2202-9-101.

46.

Comparison of the obesity phenotypes related to monosodium glutamate effect on arcuate nucleus and/or the high fat diet feeding in C57BL/6 and NMRI mice.

Matysková R, Maletínská L, Maixnerová J, Pirník Z, Kiss A, Zelezná B.

Physiol Res. 2008;57(5):727-34. Epub 2007 Oct 11.

47.

Structure-activity relationship of CART (cocaine- and amphetamine-regulated transcript) peptide fragments.

Maixnerová J, Hlavácek J, Blokesová D, Kowalczyk W, Elbert T, Sanda M, Blechová M, Zelezná B, Slaninová J, Maletínská L.

Peptides. 2007 Oct;28(10):1945-53. Epub 2007 Jul 27.

PMID:
17766010
48.

Cocaine- and amphetamine-regulated transcript (CART) peptide specific binding in pheochromocytoma cells PC12.

Maletínská L, Maixnerová J, Matysková R, Haugvicová R, Sloncová E, Elbert T, Slaninová J, Zelezná B.

Eur J Pharmacol. 2007 Mar 22;559(2-3):109-14. Epub 2007 Jan 17.

PMID:
17292884
49.

Relationship among nitric oxide, leptin, ACTH, corticosterone, and IL-1beta, in the early and late phases of adjuvant arthritis in male Long Evans rats.

Stofkova A, Skurlova M, Tybitanclova K, Veselsky L, Zelezna B, Jurcovicova J.

Life Sci. 2006 Nov 25;79(26):2486-91. Epub 2006 Aug 22.

PMID:
16962144
50.

Effect of cholecystokinin on feeding is attenuated in monosodium glutamate obese mice.

Maletínská L, Toma RS, Pirnik Z, Kiss A, Slaninová J, Haluzík M, Zelezná B.

Regul Pept. 2006 Sep 11;136(1-3):58-63. Epub 2006 Jun 19.

PMID:
16782213

Supplemental Content

Loading ...
Support Center